Provided by Tiger Trade Technology Pte. Ltd.

Rhythm Pharmaceuticals Inc.

113.35
+1.911.71%
Post-market: 113.350.00000.00%16:10 EDT
Volume:352.46K
Turnover:39.84M
Market Cap:7.80B
PE:-36.36
High:114.07
Open:112.73
Low:111.79
Close:111.44
52wk High:122.20
52wk Low:74.50
Shares:68.85M
Float Shares:65.39M
Volume Ratio:0.68
T/O Rate:0.54%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.1172
EPS(LYR):-3.1100
ROE:-117.04%
ROA:-30.96%
PB:75.78
PE(LYR):-36.45

Loading ...

Mar 04, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 03, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 02, 2026

Major Issues Report

Form 8-K - Current report
Feb 26, 2026

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Feb 26, 2026

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 26, 2026

Major Issues Report

Form 8-K - Current report
Feb 06, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 05, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 16, 2026

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Jan 09, 2026

Major Issues Report

Form 8-K - Current report
Dec 19, 2025

Major Issues Report

Form 8-K - Current report
Dec 11, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 11, 2025

Major Issues Report

Form 8-K - Current report
Nov 20, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 11, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 07, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 07, 2025

Major Issues Report

Form 8-K - Current report
Nov 05, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 04, 2025

Major Issues Report

Form 8-K - Current report
Oct 30, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities